Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-07-08, Stock:NVS, The news for the past five days is as follows:
2020-06-30: NEWS1: NVS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Novartis AG and Encourages Investors to Contact the Firm.
2020-07-01: NEWS1: Novartis pays $729 million to settle U.S. kickback charges.NEWS2: Amgen's Win, Netflix's Hire Send Nasdaq Higher.NEWS3: Amgen patents on top-selling arthritis drug Enbrel upheld, shares rise.
2020-07-02: NEWS1: Amgen Gets Favorable Appeals Court Ruling for Enbrel Patent.NEWS2: Novartis reaches $642m settlement with US authorities.NEWS3: The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts.NEWS4: Novartis pays $729 mln in U.S. kickback charges.NEWS5: Novartis Settles $678M Fraud Lawsuit Alleging It Bribed Doctors At Company Speaker Events.NEWS6: Novartis pays $729 million to settle U.S. kickback charges.NEWS7: Stocks - Europe Seen Higher on Virus Vaccine Optimism.
2020-07-06: NEWS1: Top Analyst Reports for Novartis, Equinix & Newmont.NEWS2: 6 Yield-Paying Stocks Trading at Cheap Prices.
2020-07-07: NEWS1: Novartis Gets EC Approval for Enerzair Breezhaler for Asthma.NEWS2: The Zacks Analyst Blog Highlights: Novartis, Equinix, Newmont, Enterprise Products Partners and Franco-Nevada.NEWS3: The Daily Biotech Pulse: Novavax Lands $1.6B For COVID-19 Vaccine, Amgen Prevails In Avastin Biosimilar Lawsuit, Cellectis Study Placed On Clinical Hold.NEWS4: Yates Class Action Law Encourages Long Term Stockholders of Novartis AG (NYSE: NVS) to Contact The Firm.

Answer: Rise